-
Iron Stress Reprograms Enterocyte Metabolism
2026-08-25
Navazesh and Ji show that both iron deficiency and iron excess produce distinct metabolic and transcriptional states in IPEC-J2 enterocytes, rather than simply opposing changes in the same pathway. By combining deferiprone or ferric ammonium citrate perturbation with inflammatory gene analysis and untargeted metabolomics, the study identifies impaired proliferation, altered energy metabolism, cholesterol remodeling, and partial recovery after iron repletion.
-
Ruxolitinib: From JAK Biology to Translation
2026-08-25
A mechanism-led guide to using Ruxolitinib (INCB018424) for myeloproliferative disorder research, oncogenic JAK2 fusion protein studies, and carefully bounded immunology investigations.
-
Ruxolitinib (INCB018424): JAK1/2 Research Guide
2026-08-24
Ruxolitinib (INCB018424) is an ATP-competitive inhibitor of JAK1 and JAK2 with nanomolar biochemical potency. Its defined selectivity, progenitor-cell activity, and reported immunomodulatory effects support mechanistic studies of myelofibrosis, myeloproliferative disorders, and tumor immune responses.
-
mCherry mRNA Workflow for Reporter Assays
2026-08-24
EZ Cap™ mCherry mRNA provides a practical red fluorescent protein mRNA control for transient expression, localization, and reporter assay workflows. Its Cap 1 structure, 5mCTP and ψUTP modifications, and optimized poly(A) tail support reproducible fluorescence while helping researchers separate delivery problems from biology-specific signals.
-
Sulfachloropyridazine: DHPS Research Guide
2026-08-23
Sulfachloropyridazine is a sulfonamide antibacterial agent that competitively inhibits dihydropteroate synthase and disrupts microbial folate synthesis. Its research value spans enzyme inhibition assay design, antimicrobial susceptibility testing, and microbiota-focused animal studies, but activity remains organism- and assay-dependent.
-
Pentoxifylline and TLR4 in Preterm Monocytes
2026-08-22
The reference study shows that pentoxifylline suppresses LPS-induced inflammatory activation in monocytes from preterm and term infants, with particularly strong effects on selected surface markers in preterm cells. By combining age-stratified whole-blood assays with flow cytometry and TLR4 mRNA analysis, it links reduced cytokine release to altered receptor expression and signaling rather than treating inflammation as an isolated endpoint.
-
TPM3 Khib, HDAC3, and Abnormal Vasoconstriction
2026-08-22
The reference study identifies HDAC3-mediated removal of 2-hydroxyisobutyrylation from TPM3 Lys141 as a mechanistic link between phenylephrine signaling and excessive vascular smooth muscle contraction. By combining co-immunoprecipitation, vascular tension assays, molecular modeling, and mutation-based validation, it establishes TPM3 Khib as a potentially actionable regulator of hypertensive vascular dysfunction.
-
Pseudo-UTP for Robust mRNA Synthesis
2026-08-21
Pseudo-UTP enables controlled pseudouridine incorporation during in vitro transcription, giving researchers a practical route to evaluate RNA stability, translation, and innate-immune behavior. This workflow connects nucleotide selection with advanced mRNA vaccine development and gene therapy RNA modification while keeping product-specific evidence separate from broader preclinical vaccine findings.
-
HBsAg–TBK1 Crosstalk in HBV Immune Evasion
2026-08-20
This Cell Death and Disease study identifies TBK1 as a molecular branch point through which hepatitis B surface antigen suppresses type I interferon signaling while promoting incomplete autophagy. Its combination of interaction mapping, pharmacological perturbation, replication assays, and tissue validation provides a framework for investigating how HBV establishes persistent infection.
-
CBD in Orofacial Inflammatory Pain: Mechanisms
2026-08-20
A 2026 Brain Research Bulletin study shows that cannabidiol (CBD) can reduce acute and chronic inflammatory pain while also improving pain-associated affective and cognitive abnormalities in mice. Its main innovation is a multi-level mechanism linking peripheral CB2 signaling, central CB1-associated endocannabinoid changes, and serotonin dynamics in the central amygdala.
-
Ruxolitinib, Mitochondrial Fission, and ATC
2026-08-19
The reference study identifies a previously underdefined link between JAK1/2–STAT3 activity, DRP1 transcription, and mitochondrial fission in anaplastic thyroid carcinoma. It shows that Ruxolitinib treatment can promote caspase-dependent apoptosis and GSDME-mediated pyroptosis in cellular and animal models, providing a mechanistic basis for further ATC research rather than clinical proof of efficacy.
-
Norovirus Co-opts NINJ1 for Selective NS1 Secretion
2026-08-19
Song et al. show that murine norovirus repurposes the host membrane protein NINJ1 to release the viral NS1 protein through a caspase-3-dependent unconventional secretion pathway. The work connects regulated membrane rupture, viral immune evasion, and selective cargo recognition, while identifying experimental strategies for dissecting NINJ1-mediated secretion in vivo.
-
2X Taq PCR Master Mix for Plant Virus Workflows
2026-08-18
Pair image-based sweetpotato virus triage with endpoint PCR confirmation using a streamlined, direct-to-gel workflow. This practical guide shows where a dye-containing Taq mix fits in genotyping, cloning, and exploratory plant disease assays—and where it does not replace quantitative or high-fidelity methods.
-
HCAR3 Structures Explain Agonist Recognition
2026-08-18
The 2025 PLOS Biology study uses cryo-EM structures and cellular cAMP assays to define how HCAR3 recognizes selective agonists and differs from HCAR2. Its analysis of binding-pocket geometry and residue-specific interactions provides a mechanistic framework for studying lipid signaling and designing HCAR3-directed ligands.
-
Pentoxifylline, TLR4, and Preterm Monocyte Inflammation
2026-08-17
The reference study shows that pentoxifylline suppresses LPS-driven inflammation in monocytes from preterm and term infants as well as adults, with particularly strong effects on selected preterm-cell markers. By combining flow cytometry, cytokine analysis, phagocytosis assays, and TLR4 transcript measurements, the work links altered monocyte phenotype to reduced TLR4 signaling and provides a useful in vitro framework for neonatal sepsis research.